Tokyo, Japan – 5 January 2007: Sosei Group Corporation (“Sosei”, TSE Mothers Index:4565) a biopharmaceutical company, today announces its intention to raise new funds by the issuance of Stock Acquisition Rights (“SARs”) and the conclusion of a Third Party Allotment Agreement with Merrill Lynch Japan Securities Co., Ltd. (“Merrill Lynch”)
The key terms of the Third Party Allotment Agreement are summarised below.
Raised funds will also be used for the development of other products where it is considered necessary for the enhancement of corporate value.
Note: This announcement is intended as general information regarding Sosei's issuance of the Stock Acquisition Rights. This announcement does not constitute or form a part of any offer or solicitation to invest in the Stock Acquisition Rights.